~16 spots leftby Jan 2028

LIFUP Neuromodulation for Healthy Controls

Recruiting in Palo Alto (17 mi)
Overseen bySudhakar Selvaraj, MD,PhD
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: The University of Texas Health Science Center, Houston
No Placebo Group

Trial Summary

What is the purpose of this trial?The purpose of this study is to assess the low-intensity focused ultrasound pulsation (LIFUP) neuromodulation on emotion processing in healthy individuals, and to assess the overall safety of the LIFUP to stimulate or inhibit brain activity in healthy volunteers.

Eligibility Criteria

This trial is for right-handed, healthy individuals who are not on drugs or psychotropic medications and have no chronic medical, psychiatric, or neurological illnesses. Women cannot be pregnant or nursing. Participants must also be comfortable with MRI scans and free from claustrophobia.

Inclusion Criteria

Must be healthy (without medical, neurological, psychiatric illness)
Must be psychotropic medication free (≥ 14 days)
Must be illicit drug-free at the time of scanning as appropriate (verified by negative urine drug screen)
+1 more

Exclusion Criteria

Must not have ongoing, chronic, or relapsing/remitting medical, psychiatric,or neurological illness as determined by a combination of history, medical record, and/or examination.
Females must not be pregnant or nursing
You cannot be claustrophobic.
+2 more

Participant Groups

The study is testing the effects of a technique called LIFUP sonication to the amygdala on emotion processing in healthy people. It aims to understand how this low-intensity focused ultrasound can stimulate or inhibit brain activity safely.
1Treatment groups
Experimental Treatment
Group I: LIFUP sonication to the amygdalaExperimental Treatment1 Intervention

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
The University of Texas Health Science Center at HoustonHouston, TX
Loading ...

Who Is Running the Clinical Trial?

The University of Texas Health Science Center, HoustonLead Sponsor

References